Since the start of 2025, the U.S. has seen more measles cases than in the previous 15 years combined, putting

its elimination status at risk and straining communities nationwide.

​

The U.S. has already reported more than 1,600 cases across 32 states in the first three months of 2026.

​

Each case inflicts real economic consequences - from health care costs to lost productivity, school disruptions, and public health response needs.

​

This interactive map shows the state-by-state economic impact of measles in 2026 to date (through April 2). Each page includes:

• Estimated costs in and beyond health care

• How outbreaks - large or small - affect local economies

• Key indicators of disease risk and preparedness

​

A 95% vaccination rate is recommended to prevent outbreaks, yet many states fall short based on the share of kindergarteners who have received the measles, mumps, and rubella (MMR) shot. At the same time, nearly half of children in most states rely on the Vaccines For Children (VFC) program for no-cost access, making stable funding and strong vaccine recommendations critical to public health and economic stability.

​

Click on your state to see the latest.

​

This analysis will be updated regularly as 2026 case counts rise. For additional information before the next update, please contact us: info@fightinfectiousdisease.org.​